Company news
Talphera, Inc. (NASDAQ:TLPH) news
Every Talphera, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Talphera to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
September 3, 2026
Talphera Announces Second Quarter 2026 Financial Results and Provides Corporate Update
August 12, 2026
Talphera to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026
August 5, 2026
Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update
May 13, 2026
Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026
May 7, 2026
Talphera Announces Two Abstracts Accepted for Presentation at AKI and CRRT 2026
March 26, 2026
Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026
March 25, 2026
Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
March 23, 2026
Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026
March 18, 2026
Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial
March 2, 2026
Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
November 12, 2025
Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025
November 5, 2025
Talphera Announces the Appointment of Joe Todisco to Board of Directors
October 21, 2025
Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market
September 8, 2025
CorMedix Announces Strategic Minority Investment in Talphera
September 8, 2025
Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial
August 25, 2025
Talphera Announces Second Quarter 2025 Financial Results and Provides Corporate Update
August 14, 2025
Talphera to Host Second Quarter Financial Results and Corporate Update Call and Webcast on Thursday, August 14, 2025
August 7, 2025
Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update
May 14, 2025
Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025
May 7, 2025
Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
March 31, 2025
Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million
March 31, 2025
Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025
March 26, 2025
Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study
January 14, 2025
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors
November 24, 2024
Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update
November 13, 2024
Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024
November 6, 2024
Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
October 8, 2024
Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
September 5, 2024
Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit
August 19, 2024
Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate Update
August 14, 2024
Talphera to Host Second Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, August 14, 2024
August 5, 2024
Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 20, 2024
Talphera to Participate at A.G.P. Virtual Healthcare Conference
May 16, 2024
Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update
May 14, 2024
Talphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024
May 2, 2024
Talphera Announces Fourth Quarter 2023 Financial Results and Provides Corporate Update
March 6, 2024
Talphera Announces Reduction in Size of its Board of Directors from Ten to Seven Members
March 1, 2024
Talphera to Host Fourth Quarter and Full-Year 2023 Financial Results Call and Webcast on March 6, 2024
February 26, 2024
Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering
January 18, 2024